These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288 [TBL] [Abstract][Full Text] [Related]
65. Transparenchymal Renal Pelvis Injection of Recombinant Adeno-Associated Virus Serotype 9 Vectors Is a Practical Approach for Gene Delivery in the Kidney. Shen X; Xu Y; Bai Z; Ma D; Niu Q; Meng J; Fan S; Zhang L; Hao Z; Zhang X; Liang C Hum Gene Ther Methods; 2018 Dec; 29(6):251-258. PubMed ID: 30458119 [TBL] [Abstract][Full Text] [Related]
66. Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure. Chaanine AH; Nonnenmacher M; Kohlbrenner E; Jin D; Kovacic JC; Akar FG; Hajjar RJ; Weber T Gene Ther; 2014 Apr; 21(4):379-386. PubMed ID: 24572786 [TBL] [Abstract][Full Text] [Related]
67. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981 [TBL] [Abstract][Full Text] [Related]
68. Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction. Piras BA; Tian Y; Xu Y; Thomas NA; O'Connor DM; French BA Gene Ther; 2016 May; 23(5):469-78. PubMed ID: 26926804 [TBL] [Abstract][Full Text] [Related]
69. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. Chu D; Sullivan CC; Weitzman MD; Du L; Wolf PL; Jamieson SW; Thistlethwaite PA J Thorac Cardiovasc Surg; 2003 Sep; 126(3):671-9. PubMed ID: 14502138 [TBL] [Abstract][Full Text] [Related]
70. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors. Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036 [TBL] [Abstract][Full Text] [Related]
71. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Sen S; Merchan J; Dean J; Ii M; Gavin M; Silver M; Tkebuchava T; Yoon YS; Rasko JE; Aikawa R Hum Gene Ther; 2010 Oct; 21(10):1327-34. PubMed ID: 20497036 [TBL] [Abstract][Full Text] [Related]
72. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169 [TBL] [Abstract][Full Text] [Related]
73. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Luebke AE; Foster PK; Muller CD; Peel AL Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894 [TBL] [Abstract][Full Text] [Related]
74. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer. Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745 [TBL] [Abstract][Full Text] [Related]
75. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling. Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250 [TBL] [Abstract][Full Text] [Related]
76. JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-mediated Transgene Expression in the Lung and Liver of Mice. Yu DL; Chow N; Wootton SK Viruses; 2020 Nov; 12(11):. PubMed ID: 33172105 [TBL] [Abstract][Full Text] [Related]
77. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360 [TBL] [Abstract][Full Text] [Related]
78. Single tyrosine mutation in AAV8 and AAV9 capsids is insufficient to enhance gene delivery to skeletal muscle and heart. Qiao C; Yuan Z; Li J; Tang R; Li J; Xiao X Hum Gene Ther Methods; 2012 Feb; 23(1):29-37. PubMed ID: 22428978 [TBL] [Abstract][Full Text] [Related]
79. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115 [TBL] [Abstract][Full Text] [Related]
80. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Dane AP; Wowro SJ; Cunningham SC; Alexander IE Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]